Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

March 1, 2027

Study Completion Date

June 1, 2028

Conditions
CancerAdverse Events
Interventions
PROCEDURE

Electroacupuncture

"Patients received electroacupuncture on the day before and the first day of each ICIs treatment cycle. The electroacupuncture points selected Zusanli (ST36), Quchi (LI11), and Hegu (LI4). Patients will be positioned supine, and the acupuncturist will disinfect the local skin at the acupuncture points using 75% ethanol on cotton balls. A disposable acupuncture needle (0.3mm × 40mm) will be inserted using either a single-hand or double-hand needling technique, with rapid, direct insertion. Once the needle reaches a depth of approximately 0.5 cun, the technique of lifting, thrusting, twirling, and rotating will be applied. After obtaining de qi, the needles will be retained for 30 minutes. Needling will be performed once every 10 minutes, and the needling technique used will be a balanced reinforcing and reducing method. Electroacupuncture will be applied using a dense-wave form, with a frequency of 2 Hz and an intensity not exceeding 10 mA."

Trial Locations (1)

810000

Qinghai, China, Qinghai Red Cross Hospital, Xining

All Listed Sponsors
lead

Qinghai Red Cross Hospital

OTHER

NCT06891521 - Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy | Biotech Hunter | Biotech Hunter